EDGAR Filing Documents for 0001564590-19-036739

Form 8-K - Current report:

SEC Accession No. 0001564590-19-036739

Filing Date

2019-10-10

Accepted

2019-10-10 06:51:32

Documents

Period of Report

2019-10-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K_AMENDED AND RESTATED LICENSE AGREEMENT AND AMENDED LOAN AGREEMENT	reta-8k_20191009.htm iXBRL	8-K	52646
2	EX-10.1	reta-ex101_174.htm	EX-10.1	829413
3	EX-10.2	reta-ex102_173.htm	EX-10.2	120614
4	EX-99.1_PR	reta-ex991_6.htm	EX-99.1	15892
5	GRAPHIC	gontxrcr00lo000001.jpg	GRAPHIC	4533
6	GRAPHIC	gontxrcr00lo000002.jpg	GRAPHIC	7269
7	GRAPHIC	gj3x3tzumohd000001.jpg	GRAPHIC	6766
8	GRAPHIC	gontxrcr00lo000003.jpg	GRAPHIC	233967
	Complete submission text file	0001564590-19-036739.txt		1596508

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	reta-20191009.xsd	EX-101.SCH	5964
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	reta-20191009_lab.xml	EX-101.LAB	20242
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	reta-20191009_pre.xml	EX-101.PRE	12081
16	EXTRACTED XBRL INSTANCE DOCUMENT	reta-8k_20191009_htm.xml	XML	3690

Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063

Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206

REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)